Company Profile
OraSure Technologies, Inc. Stock Price, News & Analysis
- Ticker:
- OSUR
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, OraSure Technologies is followed within the biotech universe for its exposure to catalyst-driven execution.
Stock performance
4.24 USD (+1.92%)
Close
Last updated: June 23, 2026 at 00:00
291.92M USD
Market cap
Why the stock is moving
OSUR is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
OraSure Technologies is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, OraSure Technologies is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
OraSure Technologies follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, OraSure Technologies sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
OraSure Technologies, Inc. Announces FDA Clearance that Expands Patient‑Friendly Access to Testing for Sexually Transmitted Infections
Source: OraSure Technologies, Inc.
- 02
OraSure Announces First Quarter 2026 Financial Results
Source: OraSure Technologies, Inc.
- 03
OraSure to Participate in Upcoming Investor Conference
Source: OraSure Technologies, Inc.
- 04
OraSure Technologies Issues Statement Regarding Altai Capital’s Intent to Nominate Director Candidates
Source: OraSure Technologies, Inc.
- 05
OraSure Submits CT/NG Molecular Self-Test and Colli-Pee™ Urine Collection Device for FDA Review
Source: OraSure Technologies, Inc.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of OraSure Technologies, Inc. (OSUR)?
OraSure Technologies, Inc. (OSUR) most recently closed at 4.24 USD, a +1.92% move versus the previous session.
What is the market cap of OraSure Technologies, Inc. (OSUR)?
OraSure Technologies, Inc. currently has a market capitalization of 291.92M USD on BioPharmSignal.
What does OraSure Technologies, Inc. do?
OraSure Technologies is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is OSUR stock listed?
OraSure Technologies, Inc. (OSUR) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, OraSure Technologies is followed within the biotech universe for its exposure to catalyst-driven execution., Biotechnology.
What is OraSure?
OraSure Technologies is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
Which conditions is OraSure Technologies, Inc. targeting with OraSure?
OraSure Technologies is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
What is Technologies?
OraSure Technologies is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.